Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Carbapenem Resistant Bacterial Infection clinical trials
1 of 2 indexed Carbapenem Resistant Bacterial Infection trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Carbapenem Resistant Bacterial Infection: 2 US clinical trials tracked, 1 recruiting.
Carbapenem Resistant Bacterial Infection is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is The Methodist Hospital Research Institute, running 1 of these trials.
Enrollment posture brief
Registry condition carbapenem-resistant-bacterial-infection
OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Carbapenem Resistant Bacterial Infection lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Carbapenem Resistant Bacterial Infection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Carbapenem Resistant Bacterial Infection is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
The Methodist Hospital Research Institute
NCT06258551
Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation
National Institutes of Health Clinical Center (CC)
NCT07226557
Phase Distribution
Phase data not available
Top Sponsors
US sites by state
Facility locations filed on Carbapenem Resistant Bacterial Infection trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Carbapenem Resistant Bacterial Infection page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Carbapenem Resistant Bacterial Infection trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- The Methodist Hospital Research Institute sponsors the most Carbapenem Resistant Bacterial Infection trials on record, review their full trial history before evaluating a specific study. See The Methodist Hospital Research Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Carbapenem Resistant Bacterial Infection condition card totals 2 registered trials; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.